How to Get Vardenafil (Levitra/Staxyn) in Michigan

Prescription access and medication affordability image for How to Get Vardenafil (Levitra/Staxyn) in Michigan

At a glance

  • Prescription required / Yes, Schedule IV equivalent controlled-substance rules do not apply; standard Rx
  • Telehealth prescribing in MI / Fully permitted under Michigan Public Health Code
  • Michigan Medicaid / Covered with prior authorization
  • Prescriber types / MD, DO, NP (with physician collaboration), PA
  • Dosage forms / Oral film-coated tablet (Levitra) and oral disintegrating tablet (Staxyn)
  • Standard dosing / 10 mg taken 30 to 60 minutes before sexual activity
  • 503A compounding / Licensed Michigan 503A pharmacies may compound vardenafil
  • Typical delivery window / 1 to 5 business days for mail-order; same-day at retail
  • Generic availability / Yes, FDA-approved generic vardenafil tablets since 2018

What Is Vardenafil and Why Is It Prescribed?

Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA in 2003 for the treatment of erectile dysfunction (ED) in adult men [1]. It works by blocking PDE5 in the corpus cavernosum, which increases cyclic guanosine monophosphate (cGMP) levels and promotes smooth-muscle relaxation during sexual stimulation [2]. The drug does not cause erections without arousal.

Two branded formulations exist. Levitra is a standard film-coated tablet available in 2.5 mg, 5 mg, 10 mg, and 20 mg strengths [1]. Staxyn is an oral disintegrating tablet (ODT) containing 10 mg of vardenafil, designed to dissolve on the tongue without water [3]. The ODT formulation uses a different salt form (vardenafil hydrochloride trihydrate vs. monohydrochloride trihydrate) and is not interchangeable milligram-for-milligram with Levitra tablets [3].

In the key registration trial by Porst et al. (N=580), vardenafil 10 mg and 20 mg significantly improved the International Index of Erectile Function (IIEF) erectile function domain score compared with placebo (p<0.0001 for both doses) [4]. A later fixed-dose study (N=762) confirmed that 72% of intercourse attempts were successful with vardenafil 20 mg versus 51% with placebo [5]. Onset of action occurs as early as 15 minutes post-dose in some men, with a median Tmax of approximately 60 minutes [1].

Generic vardenafil film-coated tablets received FDA approval in 2018, lowering out-of-pocket costs considerably [6]. Michigan residents now have access to both branded and generic options through retail chains and mail-order pharmacies.

Michigan Telehealth Rules for ED Prescriptions

Michigan law permits telehealth prescribing for erectile dysfunction. Under Michigan's Public Health Code (MCL 333.16284), a prescriber may establish a provider-patient relationship through a real-time audio-video encounter, and the Michigan Board of Medicine has not carved out ED medications from telehealth eligibility [7]. This means a licensed prescriber in Michigan (or one holding an active Michigan license while located elsewhere) can evaluate, diagnose, and prescribe vardenafil entirely online.

A telehealth ED visit typically includes a review of sexual health history, cardiovascular risk screening, a medication reconciliation to check for nitrate use or alpha-blocker interactions, and a review of recent labs if available [8]. The American Urological Association (AUA) guidelines state that PDE5 inhibitors are first-line therapy for ED and do not mandate in-person examination before prescribing in straightforward cases [9].

HealthRX operates as a telehealth platform that connects Michigan residents with board-certified clinicians who can prescribe vardenafil after an online evaluation. Visits are asynchronous or synchronous depending on clinical complexity. Prescriptions are sent electronically to the patient's preferred pharmacy.

Michigan residents in the Upper Peninsula and rural counties often face 60-plus-mile drives to the nearest urologist. Telehealth prescribing removes that barrier entirely.

Who Can Prescribe Vardenafil in Michigan?

Several categories of licensed clinicians in Michigan may prescribe vardenafil. Physicians (MD and DO) have full, independent prescribing authority. Nurse practitioners (NPs) in Michigan practice under a collaborative agreement with a physician and may prescribe legend drugs including PDE5 inhibitors within their scope [10]. Physician assistants (PAs) prescribe under delegated authority from their supervising physician [10].

The AUA recommends that any prescriber evaluate baseline cardiovascular risk before initiating PDE5 inhibitor therapy [9]. The Princeton III Consensus guidelines classify patients into low, intermediate, or high cardiovascular risk categories [11]. Low-risk patients (e.g., controlled hypertension, mild stable angina, successful coronary revascularization) can safely receive PDE5 inhibitors without additional cardiac workup [11]. Intermediate-risk patients may need exercise stress testing before starting therapy.

Vardenafil carries an absolute contraindication with nitrate medications (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) due to the risk of severe hypotension [1]. Concomitant use of potent CYP3A4 inhibitors such as ketoconazole or ritonavir requires dose reduction to 2.5 mg [1]. Alpha-blockers used for benign prostatic hyperplasia (tamsulosin, alfuzosin) require a stable-dose interval before vardenafil initiation [12].

What Labs Are Needed Before Starting Vardenafil?

No single mandatory lab panel exists for vardenafil prescribing, but clinical guidelines support targeted testing. The Endocrine Society recommends measuring morning total testosterone in men with ED, since hypogonadism is present in roughly 12% to 35% of men presenting with erectile complaints [13]. A fasting lipid panel and hemoglobin A1c may be indicated because diabetes and dyslipidemia are independent ED risk factors, with ED prevalence reaching 52% in men with type 2 diabetes according to a cross-sectional analysis (N=1,460) [14].

A basic metabolic panel helps assess renal function, relevant because vardenafil is hepatically metabolized but renal impairment may signal broader vascular disease [1]. For men on anticoagulants or with a history of priapism, a complete blood count and sickle cell screen are appropriate.

In practice, many telehealth providers accept labs drawn within the previous 12 months. HealthRX clinicians will request specific labs if the clinical history suggests an underlying endocrine or metabolic issue. The AUA emphasizes that routine hormonal testing should accompany ED evaluation, not replace it [9].

Michigan Medicaid Coverage and Prior Authorization

Michigan Medicaid (through the Michigan Department of Health and Human Services) covers vardenafil for erectile dysfunction, but requires prior authorization (PA) [15]. The PA process confirms medical necessity and rules out contraindicated medications.

Documentation typically required for Michigan Medicaid PA includes a confirmed diagnosis of erectile dysfunction (ICD-10 code N52.9 or more specific subtypes), documentation that the prescriber has reviewed the patient's current medication list for nitrate contraindications, a clinical note describing the impact on quality of life, and evidence that no absolute contraindications exist.

PA turnaround in Michigan Medicaid is generally 24 to 72 hours for standard requests. Urgent requests can be processed within 24 hours. If denied, the prescriber may file a redetermination request with additional clinical documentation.

Commercial insurers in Michigan vary. Some Blue Cross Blue Shield of Michigan plans cover generic vardenafil with a quantity limit (commonly 6 to 12 tablets per month). Priority Health and HAP plans often require step therapy, requiring a trial of sildenafil before approving vardenafil. A 2020 analysis of commercial insurer formularies found that 68% placed generic PDE5 inhibitors on tier 2 or tier 3 [16].

For patients paying out of pocket, generic vardenafil 20 mg tablets range from approximately $2 to $8 per tablet at Michigan retail pharmacies, compared with $50 to $70 per tablet for branded Levitra [6].

Pharmacy Access: Retail, Mail-Order, and 503A Compounding

Michigan residents can fill a vardenafil prescription at any licensed retail pharmacy. Major chains (CVS, Walgreens, Meijer, Rite Aid) stock generic vardenafil tablets. Meijer operates over 160 pharmacy locations across Michigan, offering competitive generic pricing.

Mail-order pharmacy is another option. Michigan permits licensed out-of-state pharmacies to ship prescription medications to Michigan addresses, provided the pharmacy holds a Michigan nonresident pharmacy license issued by the Michigan Board of Pharmacy (MCL 333.17748) [17]. Delivery typically takes 1 to 5 business days via standard shipping.

Michigan also licenses 503A compounding pharmacies under the Board of Pharmacy's oversight [17]. A 503A pharmacy may compound vardenafil pursuant to a valid patient-specific prescription when a commercially available product does not meet the patient's needs (e.g., a patient who cannot swallow tablets and needs a sublingual troche, or a patient who requires a non-standard dose). The FDA's guidance on 503A compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act requires an individual patient prescription and prohibits large-scale manufacturing [18].

Patients should verify that any compounding pharmacy holds an active Michigan license through the Michigan LARA (Licensing and Regulatory Affairs) database.

Vardenafil vs. Other PDE5 Inhibitors Available in Michigan

Michigan prescribers have access to four FDA-approved PDE5 inhibitors: sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra/Staxyn), and avanafil (Stendra). Each has distinct pharmacokinetic properties that influence clinical selection.

Vardenafil has a half-life of 4 to 5 hours, similar to sildenafil (3 to 5 hours) but shorter than tadalafil (17.5 hours) [1]. Avanafil has the fastest reported onset at 15 minutes but a half-life of roughly 5 hours [19]. A meta-analysis of 82 randomized controlled trials (N=47,626) comparing PDE5 inhibitors found no statistically significant difference in overall efficacy among the four drugs for general ED populations [20].

Vardenafil may hold an advantage in specific populations. A subgroup analysis from a pooled dataset (N=3,489) found that vardenafil 20 mg produced a statistically significant improvement in IIEF scores in men with diabetes-related ED, with 57% reporting successful intercourse versus 36% on placebo [21]. In men who had undergone bilateral nerve-sparing radical prostatectomy, vardenafil 20 mg improved erections sufficient for intercourse in 65% of attempts compared with 48% for placebo [22].

The choice between vardenafil and alternatives often comes down to timing preference, side-effect profile, and insurance formulary position. Vardenafil is associated with a slightly lower incidence of visual disturbance compared with sildenafil [20]. Tadalafil's longer half-life makes it the preferred option for daily dosing regimens.

How to Transfer a Vardenafil Prescription to Michigan

Patients relocating to Michigan or visiting from another state can transfer an existing vardenafil prescription. Michigan Board of Pharmacy rules allow prescription transfers between retail pharmacies via direct pharmacist-to-pharmacist communication [17]. The transferring pharmacist provides the prescription number, drug, strength, quantity, refills remaining, prescriber information, and patient details.

For controlled substances, transfer rules are stricter, but vardenafil is not a DEA-scheduled controlled substance, which simplifies the process [1]. A single phone call between pharmacies is typically sufficient.

Patients using a telehealth provider based outside Michigan should confirm that the prescriber holds an active Michigan medical license. Michigan does not honor out-of-state telehealth prescriptions from unlicensed providers under current interstate practice rules [7]. The Interstate Medical Licensure Compact, which Michigan joined, does allow physicians with Compact licenses to practice across member states.

Safety Considerations and Contraindications

Vardenafil's FDA label lists several contraindications and precautions that Michigan prescribers must review [1]. The most critical is concomitant nitrate use. A study of hemodynamic interactions showed that vardenafil 20 mg combined with sublingual nitroglycerin 0.4 mg produced a maximum mean decrease in standing systolic blood pressure of 23 mmHg, compared with 7 mmHg for nitroglycerin alone [23].

QT prolongation is a known pharmacological effect of vardenafil at supratherapeutic doses. The FDA label notes a mean QTc increase of 8 ms at the 40 mg dose (twice the maximum recommended dose) [1]. Vardenafil should be avoided in patients with congenital long QT syndrome or those taking Class IA or III antiarrhythmics (e.g., quinidine, sotalol, amiodarone).

Common side effects reported in clinical trials include headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%) [4]. Rare but serious adverse events include non-arteritic anterior ischemic optic neuropathy (NAION), sudden sensorineural hearing loss, and priapism lasting more than 4 hours [1]. The FDA issued a 2007 labeling update to include NAION risk across all PDE5 inhibitors [24].

Patients with hepatic impairment (Child-Pugh B) should start at 5 mg, and vardenafil is not recommended in severe hepatic impairment (Child-Pugh C) [1].

Step-by-Step: Getting Vardenafil in Michigan

The process from initial consultation to medication in hand typically follows a straightforward sequence. First, schedule an evaluation with a Michigan-licensed prescriber, either in person or via a telehealth platform such as HealthRX. Second, complete a medical intake that covers sexual health history, cardiovascular risk factors, and current medications. Third, provide or complete any requested laboratory work (testosterone, metabolic panel, A1c if indicated). Fourth, if the prescriber determines vardenafil is appropriate, an electronic prescription is sent to your chosen pharmacy. Fifth, if your insurance requires prior authorization, your prescriber's office submits the PA request. Sixth, pick up at a local pharmacy or receive via mail-order delivery within 1 to 5 business days.

For men using HealthRX, the median time from completed intake to prescription sent is under 24 hours for straightforward cases without PA requirements. Michigan patients in urban areas (Detroit, Grand Rapids, Ann Arbor, Lansing) generally have same-day retail pickup available.

The recommended starting dose is 10 mg, taken approximately 60 minutes before anticipated sexual activity, with or without food [1]. Based on efficacy and tolerability, the dose may be increased to 20 mg or decreased to 5 mg. Maximum dosing frequency is once per 24-hour period [1].

Frequently asked questions

How do I get a vardenafil (Levitra/Staxyn) prescription in Michigan?
Schedule an in-person or telehealth visit with a Michigan-licensed MD, DO, NP, or PA. After reviewing your medical history and checking for contraindications such as nitrate use, the prescriber can send an electronic prescription to any Michigan pharmacy. HealthRX offers telehealth evaluations for Michigan residents.
What labs are needed before vardenafil in Michigan?
No universal lab requirement exists, but most prescribers request a morning total testosterone level and may add a fasting lipid panel, hemoglobin A1c, and basic metabolic panel based on your risk profile. Labs drawn within the prior 12 months are often accepted.
Are there telehealth providers in Michigan prescribing vardenafil?
Yes. Michigan law permits telehealth prescribing for ED medications including vardenafil. HealthRX and other licensed telehealth platforms connect Michigan residents with board-certified clinicians for evaluation and prescribing.
How long until I receive vardenafil in Michigan?
Retail pharmacy pickup is available same-day once the prescription is processed. Mail-order delivery typically takes 1 to 5 business days. If prior authorization is required, add 1 to 3 business days for approval.
Can I transfer a vardenafil prescription to Michigan?
Yes. Vardenafil is not a DEA-scheduled substance, so a pharmacist-to-pharmacist transfer is straightforward. Your new Michigan pharmacy contacts your previous pharmacy directly. Ensure any telehealth prescriber holds an active Michigan license.
Are 503A pharmacies in Michigan licensed to ship vardenafil?
Michigan-licensed 503A compounding pharmacies may compound and dispense vardenafil pursuant to a valid patient-specific prescription. Verify the pharmacy's active license through the Michigan LARA database before ordering.
Who can prescribe vardenafil in Michigan: MD vs NP vs PA?
MDs and DOs have independent prescribing authority. NPs prescribe under a collaborative agreement with a physician, and PAs prescribe under delegated authority from a supervising physician. All three provider types may prescribe vardenafil for ED in Michigan.
What documentation does prior authorization require in Michigan?
Michigan Medicaid PA typically requires a confirmed ED diagnosis (ICD-10 N52.x), documentation that nitrate contraindications have been reviewed, a clinical note on quality-of-life impact, and confirmation that no absolute contraindications exist. Commercial insurers may have additional formulary-specific requirements.
Is generic vardenafil available in Michigan?
Yes. FDA-approved generic vardenafil tablets have been available since 2018. Generic pricing at Michigan retail pharmacies typically ranges from $2 to $8 per 20 mg tablet, compared with $50 to $70 for branded Levitra.
Does vardenafil interact with blood pressure medications?
Vardenafil is absolutely contraindicated with nitrates. Alpha-blockers for BPH require dose stabilization before starting vardenafil. Other antihypertensives may cause additive blood pressure lowering, so prescribers adjust based on baseline readings.

References

  1. FDA. Levitra (vardenafil hydrochloride) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s012lbl.pdf
  2. Corbin JD, Francis SH. Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract. 2002;56(6):453-459. https://pubmed.ncbi.nlm.nih.gov/12166544/
  3. FDA. Staxyn (vardenafil hydrochloride) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022206s000lbl.pdf
  4. Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
  5. Hellstrom WJ, Gittelman M, Karlin G, et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl. 2002;23(6):763-771. https://pubmed.ncbi.nlm.nih.gov/12399514/
  6. FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Vardenafil hydrochloride. https://www.accessdata.fda.gov/scripts/cder/ob/
  7. Michigan Legislature. Public Health Code, MCL 333.16284. Telehealth practice standards. https://www.michigan.gov/lara
  8. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline (2018). J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
  9. American Urological Association. Erectile dysfunction: AUA guideline amendment 2023. https://pubmed.ncbi.nlm.nih.gov/29746858/
  10. Michigan Board of Nursing. Nurse practitioner practice and prescribing FAQ. https://www.michigan.gov/lara
  11. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22862865/
  12. Kloner RA. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors. Am J Cardiol. 2005;96(12B):37M-46M. https://pubmed.ncbi.nlm.nih.gov/16387565/
  13. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  14. Kouidrat Y, Pizzol D, Cosco T, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis. Diabet Med. 2017;34(9):1185-1192. https://pubmed.ncbi.nlm.nih.gov/28164418/
  15. Michigan Department of Health and Human Services. Medicaid pharmacy prior authorization criteria. https://www.michigan.gov/mdhhs
  16. Jena AB, Goldman D, Karaca-Mandic P. Trends in prescription drug coverage for erectile dysfunction medications. JAMA Intern Med. 2020;180(5):1-3. https://jamanetwork.com/journals/jamainternalmedicine
  17. Michigan Board of Pharmacy. General rules and pharmacy licensure. MCL 333.17748. https://www.michigan.gov/lara
  18. FDA. Guidance for industry: Compounding and the FDA: Questions and answers. Section 503A. https://www.fda.gov/drugs/human-drug-compounding/mixing-manipulating-or-diluting-sterile-products
  19. Goldstein I, McCullough AR, Jones LA, et al. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med. 2012;9(4):1122-1133. https://pubmed.ncbi.nlm.nih.gov/22248153/
  20. Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912. https://pubmed.ncbi.nlm.nih.gov/23395275/
  21. Goldstein I, Young JM, Fischer J, et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes. Diabetes Care. 2003;26(3):777-783. https://pubmed.ncbi.nlm.nih.gov/12610037/
  22. Brock G, Nehra A, Lipshultz LI, et al. Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol. 2003;170(4 Pt 1):1278-1283. https://pubmed.ncbi.nlm.nih.gov/14501741/
  23. Kloner RA, Jackson G, Emmick JT, et al. Interaction between the phosphodiesterase 5 inhibitor, vardenafil and nitroglycerin. J Am Coll Cardiol. 2003;42(10):1855-1860. https://pubmed.ncbi.nlm.nih.gov/14642700/
  24. FDA. FDA announces revisions to labels for Cialis, Levitra, and Viagra. Safety announcement, 2007. https://www.fda.gov/drugs/drug-safety-and-availability